Abstract
Metamorphosis, the transformation of one normal tissue or organ system into another, is a biological process rarely studied in higher vertebrates or mammals, but exemplified pathologically by the extremely disabling autosomal dominant disorder fibrodysplasia ossificans progressiva (FOP). The recurrent single nucleotide missense mutation in the gene encoding activin receptor IA/activin-like kinase-2 (ACVR1/ALK2), a bone morphogenetic protein type I receptor that causes skeletal metamorphosis in all classically affected individuals worldwide, is the first identified human metamorphogene. Physiological studies of this metamorphogene are beginning to provide deep insight into a highly conserved signaling pathway that regulates tissue stability following morphogenesis, and that when damaged at a highly specific locus (c.617G > A; R206H), and triggered by an inflammatory stimulus permits the renegade metamorphosis of normal functioning connective tissue into a highly ramified skeleton of heterotopic bone. A comprehensive understanding of the process of skeletal metamorphosis, as revealed by the rare condition FOP, will lead to the development of more effective treatments for FOP and, possibly, for more common disorders of skeletal metamorphosis.
Similar content being viewed by others
References
Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2005) Introduction. Clin Rev Bone Miner Metab 3(3–4):175–177
Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P, Morhart R, Smith R, Le Merrer M, Rogers JG, Connor JM, Kitterman JA (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:183–188
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, Le Merrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossi-ficans progressiva. Nat Genet 38:525–527
Cohen RB, Hahn GV, Tabas J, Peeper J, Levitz CL, Sando A, Sando N, Zasloff M, Kaplan FS (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 75:215–219
Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS (1994) Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 301:243–248
Kaplan FS, Tabas J, Gannon FH, Finkel G, Hahn GV, Zasloff MA (1993) The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg Am 75:220–230
Gannon FH, Valentine BA, Shore EM, Zasloff MA, Kaplan FS (1998) Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 346:19–25
Glaser DL, Economides AN, Wang L, Liu X, Kimble RD, Fandl JP, Wilson JM, Stahl N, Kaplan FS, Shore EM (2003) In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 85:2332–2342
Pignolo RJ, Suda RK, Kaplan FS (2005) The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab 3:195–200
Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS (1995) Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr 126:762–764
Janoff HB, Zasloff MA, Kaplan FS (1996) Submandibular swelling in patients with fibrodysplasia ossificans progressiva. Otolaryngol Head Neck Surg 114:599–604
Luchetti W, Cohen RB, Hahn GV, Rocke DM, Helpin M, Zasloff M, Kaplan FS (1996) Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:21–25
Glaser DL, Rocke DM, Kaplan FS (1998) Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 346:110–116
Scarlett RF, Rocke DM, Kantanie S, Patel JB, Shore EM, Kaplan FS (2004) Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 423:275–279
Connor JM, Evans DA (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64:76–83
Smith R (1988) Fibrodysplasia (myositis) ossificans progressiva: clinical lessons from a rare disease. Clin Orthop Relat Res 346:7–14
Kaplan FS, Shore EM, Connor JM (2002) Fibrodysplasia ossificans progressiva (FOP). In: Royce PM, Steinmann B (eds) Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd edn. Wiley-Liss, New York, pp 827–840
Kaplan FS, Glaser DL, Hebela N, Shore EM (2004) Heterotopic ossification. J Am Acad Orthop Surg 12:116–125
Kaplan FS, Glaser DL, Shore EM (2006) Fibrodysplasia (myositis) ossificans progressiva. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th edn. The American Society for Bone and Mineral Research, Washington, DC, pp 450–453
Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS (1997) Limb swelling in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 336:247–253
Kaplan FS, Glaser DL (2005) Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:213–216
Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:201–204
Kitterman JA, Kantanie S, Rocke DM, Kaplan FS (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 116:654–661
Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, Ganguly A, Shore E (2008) Early diagnosis of fibrodysplasia ossificans progressiva (FOP). Pediatrics 121:e1295–1300
Schaffer AA, Kaplan FS, Tracy MR, O’Brien ML, Dormans JP, Shore EM, Harland RM, Kusumi K (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome. Spine 30:1379–1385
Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides A, Kwaitowski W, Affolter M, Vale WW, Izpisua-Belmonte JC, Choe S (2002) Structural basis of BMP signalling inhibition by Noggin, a novel cystine knot protein. Nature (Lond) 420:636–642
Lucotte G, Semonin O, Lutz P (1999) A de novo heterozygous deletion of 42 base-pairs in the noggin gene of a fibrodysplasia ossificans progressiva. Clin Genet 56:469–470
Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 102:314–317
Lucotte G, La Garde JP, and members of the FOP European Research Group (2007) Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP). Genet Couns 18:349–352
Xu M-Q, Feldman G, Le Merrer M, Shugart YY, Glaser DL, Urtizberea JA, Fardeau M, Connor JM, Triffitt J, Smith R, Shore EM, Kaplan FS (2000) Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva. Clin Genet 58:291–298
Cohen MM Jr (2002) Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and noggin. Am J Med Genet 109:87–92
Carey JC (2002) Editor’s note. Am J Med Genet 109:160
Xu M, Shore EM, Kaplan FS (2002) Reported noggin mutations are PCR errors. Am J Med Genet 109:161
Warman ML (2002) Significant difference of opinion regarding the role of noggin in fibrodysplasia ossificans progressiva. Am J Med Genet 109:162
Deirmengian GK, Hebela NM, O’Connell M, Glaser DL, Shore EM, Kaplan FS (2008) Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva (FOP). J Bone Joint Surg Am 90:366–374
Kaplan FS, McCluskey W, Hahn G, Tabas J, Muenke M, Zasloff MA (1993) Genetic transmission of fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 75:1214–1220
Hebela N, Shore EM, Kaplan FS (2005) Three pairs of monozygotic twins with fibrodysplasia ossificans progressiva: the role of environment in the progression of heterotopic ossification. Clin Rev Bone Miner Metab 3:205–208
Kaplan FS, Groppe J, Pignolo RJ, Shore EM (2007) Morphogen receptor genes and metamorphogenes: skeleton keys to the metamorphosis. Ann N Y Acad Sci 1116:113–133
Urist MR (1965) Bone formation by autoinduction. Science 150:893–899
Urist MR, Nakagawa M, Nakata N, Nogami H (1978) Experimental, myositis ossificans: cartilage and bone formation in muscle in response to a diffusable bone matrix-derived morphogen. Arch Pathol Lab Med 102:312–316
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534
Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS (2001) Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol 32:842–848
Kan L, Hu M, Gomes WA, Kessler JA (2004) Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107–1115
Kan L (2005) The neuron-specific enolase-bone morphogenetic protein 4 transgenic mouse. Clin Rev Bone Miner Metab 3: 235–237
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755–1766
Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T (1997) Constitutively active BMP type I receptors transduce BMP2 signals without the ligand in C2C12 myoblasts. Exp Cell Res 235:362–369
Massagué J (2000) How cells read TGF-β signals. Nat Rev Mol Cell Biol 1:169–178
Hoffman A, Gross G (2001) BMP signaling pathways in cartilage and bone formation. Crit Rev Eukaryot Gene Expr 11:23–45
ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ (2003) Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 211:105–113
Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL, Goumans MJ (2003) BMP signaling components are expressed in human fracture callus. Bone (NY) 33:362–371
Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51–65
Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700
Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783–2810
Schmierer B, Hill CS (2007) TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Mol Cell Biol 8:970–982
Lander AD (2007) Morpheus unbound: reimagining the morphogen gradient. Cell 128:245–256
Kaplan FS, Tabas JA, Zasloff MA (1990) Fibrodysplasia ossificans progressiva (FOP): a clue from the fly? Calcif Tissue Int 47: 117–125
Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS (1996) Over-expression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335: 555–561
Gannon FH, Kaplan FS, Olmsted E, Finkel G, Zasloff MA, Shore EM (1997) Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum Pathol 28: 339–343
Ahn J, Serrano de la Peña L, Shore EM, Kaplan FS (2003) Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am 85:667–674
Serrano de la Peña L, Billings PC, Fiori JL, Ahn J, Shore EM, Kaplan FS (2005) Fibrodysplasia ossificans progressiva, a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res 20:1168–1176
Fiori JL, Billings PC, Serrano de la Peña L, Kaplan FS, Shore EM (2006) Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva. J Bone Miner Res 21:902–909
Kaplan FS, Fiori J, Serrano de la Peña L, Ahn J, Billings PC, Shore EM (2006) Dysregulation of the BMP4 signaling pathway in fibrodysplasia ossificans progressiva. Ann N Y Acad Sci 1068: 54–65
Billings PC, Fiori JL, Bentwood JL, O’Connell MP, Jiao X, Nussbaum B, Caron RJ, Shore EM, Kaplan FS (2008) Dysregulated BMP4 signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva. J Bone Miner Res 23:305–313
Harradine KA, Akhurst RJ (2006) Mutations of TGF-β signaling molecules in human disease. Ann Med 38:403–414
Zhang D, Schwarz EM, Rosier RN, Zuscik MJ, Puzas JE, O’Keefe RJ (2003) Alk2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 18:1593–1604
Fukada T, Kohda M, Kanomata K, Nojima J, Kamizono J, Oda H, Nakayama K, Ohtake A, Miyazono K, Jimi E, Owan I, Okazaki Y, Katagiri T (2007) A constitutively activated BMP receptor, ALK2, induces heterotopic bone formation in patients with fibrodysplasia ossificans progressiva. J Bone Miner Res 22(suppl 1): S10
Shen Q, Xu M, Little SC, Kaplan FS, Mullins MC, Shore EM (2007) Activation of BMP signaling by the FOP ACVR1 R206H mutation. J Bone Miner Res 22(suppl 1):S43
Groppe JC, Shore EM, Kaplan FS (2007) Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res 462:87–92
Wang T, Li B-Y, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGF-β family type I receptors. Cell 86:435–444
Chen Y-G, Liu F, Massagué J (1997) Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J 16:3866–3876
Huse M, Chen YG, Massagué J, Kuriyan J (1999) Crystal structure of the cytoplasmic domain of the type I TGF-β receptor complex with FKBP12. Cell 96:425–436
Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagué J (2001) The TGF-β receptor activation process: an inhibitor-to-substrate binding switch. Mol Cell 8:671–682
Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K (2001) Smurf1 interacts with transforming growth factor-β type 1 receptor through Smad 7 and induces receptor degradation. J Biol Chem 276:12477–12480
Yamaguchi T, Kurisaki A, Yamakawa N, Minakuchi K, Sugino H (2006) FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor. J Mol Endocrinol 36:569–579
Kaplan FS, Shore EM, Gupta R, Billings PC, Glaser DL, Pignolo RJ, Graf D, Kamoun M (2005) Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP4 pathway. Clin Rev Bone Miner Metab 3:189–193
Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR (2007) Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 170:620–632
Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA, Groppe J, Shore EM (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191–205
Hakim M, Hage W, Lovering RM, Moorman CT III, Curl LA, De Deyne PG (2005) Dexamethasone and recovery of contractile tension after a muscle injury. Clin Orthop Relat Res 439:235–242
Järvinen TA, Järvinen TL, Kääriäinen M, Kalimo H, Järvinen M (2005) Muscle injuries: biology and treatment. Am J Sports Med 33:745–764
Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524–529
Vanden Bossche LC, Van Maele G, Wojtowicz I, De Cock K, Vertriest S, De Muynck M, Rimbaut S, Vanderstraeten GG (2007) Free radical scavengers are more effective than indomethacin in the prevention of experimentally induced heterotopic ossification. J Orthop Res 25:267–272
Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS (2001) Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865–2876
Pfander D, Cramer T, Schipani E, Johnson RS (2003) HIF-1-alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116:1819–1826
Provot S, Ziny KD, Gunes Y, Kathri R, Le Q, Kronenberg HM, Johnson RS, Longaker MT, Giaccia AJ, Schipani E (2007) Hif-1-alpha regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 177:451–464
Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG (2007) Hematopoietic stemcell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89:347–357
Stoick-Cooper CL (2007) Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine. Genes Dev 21:1292–1315
Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:243–250
Shah PB, Zasloff MA, Drummond D, Kaplan FS (1994) Spinal deformity in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 76:1442–1450
Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2007) A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther 7:705–712
Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4:33–41
Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS (2001) Bone formation and inflammation in cardiac valves. Circulation 20:1522–1528
Pignolo RJ, Foley KL (2005) Nonhereditary heterotopic ossification: implications for injury, arthropathy, and aging. Clin Rev Bone Miner Metab 3:261–266
Wolf JM (2006) The genetic key to a rare disease and its impact on orthopedics. Orthopedics 29:672
Potter BK, Burns TC, Lacap AP, Granville RR, Gajkewski D (2006) Heterotopic ossification in the residual limbs of traumatic and combat-related amputees. J Am Acad Orthop Surg 14: S191–S197
Kaplan FS (2006) The key to the closet is the key to the kingdom: a common lesson of rare diseases. Orphan Disease Update 24:1–9
Willis R (1989) The Works of William Harvey. University of Pennsylvania Press, Philadelphia, pp 616-617
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kaplan, F.S., Shen, Q., Lounev, V. et al. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab 26, 521–530 (2008). https://doi.org/10.1007/s00774-008-0879-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-008-0879-8